Bharat Biotech’s Covaxin caused hospitalisation during early trials due to ‘adverse reaction’
Covaxin is conducting Phase III vaccine trails in India (File photo) India is waiting anxiously for Covaxin, the indigenously made Covid-19 vaccine, which started with its third phase trials in Odisha. As the Centre prepares for a mega drive, the vaccine maker recently reported to the Drug Controller General of India about a participant developing … Read more